BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 27590381)

  • 1. Gene set-based integrative analysis of ovarian clear cell carcinoma.
    Chang CM; Chiou SH; Yang MJ; Yen MS; Wang PH
    Taiwan J Obstet Gynecol; 2016 Aug; 55(4):552-7. PubMed ID: 27590381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene set-based analysis of mucinous ovarian carcinoma.
    Chang CM; Wang PH; Horng HC
    Taiwan J Obstet Gynecol; 2017 Apr; 56(2):210-216. PubMed ID: 28420510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulated immunological and metabolic functions discovered by a polygenic integrative analysis for PCOS.
    Ho CH; Chang CM; Li HY; Shen HY; Lieu FK; Wang PS
    Reprod Biomed Online; 2020 Jan; 40(1):160-167. PubMed ID: 31780352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Set-Based Functionome Analysis of Pathogenesis in Epithelial Ovarian Serous Carcinoma and the Molecular Features in Different FIGO Stages.
    Chang CM; Chuang CM; Wang ML; Yang MJ; Chang CC; Yen MS; Chiou SH
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27275818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovering the Deregulated Molecular Functions Involved in Malignant Transformation of Endometriosis to Endometriosis-Associated Ovarian Carcinoma Using a Data-Driven, Function-Based Analysis.
    Chang CM; Yang YP; Chuang JH; Chuang CM; Lin TW; Wang PH; Yu MH; Chang CC
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Potential Role of Complement System in the Progression of Ovarian Clear Cell Carcinoma Inferred from the Gene Ontology-Based Immunofunctionome Analysis.
    Su KM; Lin TW; Liu LC; Yang YP; Wang ML; Tsai PH; Wang PH; Yu MH; Chang CM; Chang CC
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiles in three histologic types, clear-cell, endometrioid and serous ovarian carcinomas.
    Pamuła-Piłat J; Rubel T; Rzepecka IK; Olbryt M; Herok R; Dansonka-Mieszkowska A; Grzybowska E; Kupryjańczyk J
    J Biol Regul Homeost Agents; 2014; 28(4):659-74. PubMed ID: 25620176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Set-Based Integrative Analysis Revealing Two Distinct Functional Regulation Patterns in Four Common Subtypes of Epithelial Ovarian Cancer.
    Chang CM; Chuang CM; Wang ML; Yang YP; Chuang JH; Yang MJ; Yen MS; Chiou SH; Chang CC
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key Immunological Functions Involved in the Progression of Epithelial Ovarian Serous Carcinoma Discovered by the Gene Ontology-Based Immunofunctionome Analysis.
    Chang CC; Su KM; Lu KH; Lin CK; Wang PH; Li HY; Wang ML; Lin CK; Yu MH; Chang CM
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30356023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulated Immunological Functionome and Dysfunctional Metabolic Pathway Recognized for the Pathogenesis of Borderline Ovarian Tumors by Integrative Polygenic Analytics.
    Chang CM; Li YF; Lin HC; Lu KH; Lin TW; Liu LC; Su KM; Chang CC
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative analysis of copy number alteration and gene expression profiling in ovarian clear cell adenocarcinoma.
    Sung CO; Choi CH; Ko YH; Ju H; Choi YL; Kim N; Kang SY; Ha SY; Choi K; Bae DS; Lee JW; Kim TJ; Song SY; Kim BG
    Cancer Genet; 2013 May; 206(5):145-53. PubMed ID: 23726144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
    Zorn KK; Bonome T; Gangi L; Chandramouli GV; Awtrey CS; Gardner GJ; Barrett JC; Boyd J; Birrer MJ
    Clin Cancer Res; 2005 Sep; 11(18):6422-30. PubMed ID: 16166416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Gene Clusters in Global Pathogenesis of Clear Cell Carcinoma of the Ovary Discovered by Integrated Analysis of Transcriptomes.
    Hsu YH; Wang PH; Chang AC
    Int J Environ Res Public Health; 2020 Jun; 17(11):. PubMed ID: 32498447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene expression profiling of human ovarian epithelial tumors by digo nucleotide microarray].
    Konno R
    Hum Cell; 2001 Dec; 14(4):261-6. PubMed ID: 11925926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.
    Uehara Y; Oda K; Ikeda Y; Koso T; Tsuji S; Yamamoto S; Asada K; Sone K; Kurikawa R; Makii C; Hagiwara O; Tanikawa M; Maeda D; Hasegawa K; Nakagawa S; Wada-Hiraike O; Kawana K; Fukayama M; Fujiwara K; Yano T; Osuga Y; Fujii T; Aburatani H
    PLoS One; 2015; 10(6):e0128066. PubMed ID: 26043110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality Control Usage in High-Density Microarrays Reveals Differential Gene Expression Profiles in Ovarian Cancer.
    Villegas-Ruiz V; Moreno J; Jacome-Lopez K; Zentella-Dehesa A; Juarez-Mendez S
    Asian Pac J Cancer Prev; 2016; 17(5):2519-25. PubMed ID: 27268623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma.
    Kuo KT; Mao TL; Chen X; Feng Y; Nakayama K; Wang Y; Glas R; Ma MJ; Kurman RJ; Shih IeM; Wang TL
    Clin Cancer Res; 2010 Apr; 16(7):1997-2008. PubMed ID: 20233889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas.
    Benetkiewicz M; Wang Y; Schaner M; Wang P; Mantripragada KK; Buckley PG; Kristensen G; Børresen-Dale AL; Dumanski JP
    Genes Chromosomes Cancer; 2005 Mar; 42(3):228-37. PubMed ID: 15578687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.
    Schwartz DR; Kardia SL; Shedden KA; Kuick R; Michailidis G; Taylor JM; Misek DE; Wu R; Zhai Y; Darrah DM; Reed H; Ellenson LH; Giordano TJ; Fearon ER; Hanash SM; Cho KR
    Cancer Res; 2002 Aug; 62(16):4722-9. PubMed ID: 12183431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma.
    Rahman M; Nakayama K; Rahman MT; Nakayama N; Ishikawa M; Katagiri A; Iida K; Nakayama S; Otsuki Y; Shih IeM; Miyazaki K
    Hum Pathol; 2012 Dec; 43(12):2197-206. PubMed ID: 22705003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.